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Background: Surgeons currently have difﬁculty when managing metal-on-metal hip arthroplasty (MoMHA)
patientswithadverse reactions tometaldebris (ARMD). This stems froma lackofevidence,which is emphasized
by the variability in the recommendations proposed by different worldwide regulatory authorities for consid-
eringMoMHArevisionsurgery.Weinvestigatedpredictorsofpooroutcomes followingMoMHArevisionsurgery
performed for ARMD to help inform the revision threshold and type of reconstruction.
Methods: We retrospectively studied 346 MoMHA revisions for ARMD performed at 2 European centers.
Preoperative (metal ions/imaging) and intraoperative (ﬁndings, components removed/implanted) factors
were used to predict poor outcomes. Poor outcomes were postoperative complications (including re-
revision), 90-day mortality, and poor Oxford Hip Score.
Results: Poor outcomes occurred in 38.5%. Shorter time (under 4 years) to revision surgery was the only
preoperative predictor of poor outcomes (odds ratio [OR] ¼ 2.12, conﬁdence interval [CI] ¼ 1.00-4.46).
Prerevision metal ions and imaging did not inﬂuence outcomes. Single-component revisions (vs all-
component revisions) increased the risk of poor outcomes (OR ¼ 2.99, CI ¼ 1.50-5.97). Intraoperative
modiﬁable factors reducing the risk of poor outcomes included the posterior approach (OR ¼ 0.22, CI ¼
0.10-0.49), revision head sizes 36 mm (vs <36 mm: OR ¼ 0.37, CI ¼ 0.18-0.77), ceramic-on-polyethylene
revision bearings (OR vs ceramic-on-ceramic ¼ 0.30, CI ¼ 0.14-0.66), and metal-on-polyethylene revision
bearings (OR vs ceramic-on-ceramic ¼ 0.37, CI ¼ 0.17-0.83).
Conclusion: No threshold exists for recommending revision in MoMHA patients with ARMD. However
postrevision outcomes were surgeon modiﬁable. Optimal outcomes may be achieved if surgeons use the
posterior approach, revise all MoMHA components, and use 36 mm ceramic-on-polyethylene or metal-
on-polyethylene articulations.
© 2019 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).closed potential or pertinent
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G.S. Matharu et al. / The Journal of Arthroplasty xxx (2019) 1e92Metal-on-metal hip arthroplasty (MoMHA) has been associated
with high implant failure rates [1,2], with adverse reactions to
metal debris (ARMD) representing the commonest indication for
revision [3,4]. Despite these poor outcomes of primary MoMHAs,
approximately 80% of these implants remain in-situ worldwide
[5,6]. Given the prevalence of ARMD revision surgery is increasing
[3e7], many more MoMHA patients are likely to undergo future
revision.
The frequency of complications (68%) and re-revisions (38%)
following ARMD revision have been variable [8]; however, the poor
short-term outcomes initially reported [9,10] have seemingly
improved in recent studies [11,12]. This most likely reﬂects more reg-
ular MoMHA patient surveillance and surgeons lowering their
threshold for revision given the initial poor outcomes of revisions
[9,13e15]. However, little good evidence exists regarding outcomes
followingARMDrevision,witha recent systematic reviewhighlighting
that studies generally involved small (<100 patients) single-center
cohorts with short-term follow-up (mean 3 years) [8]. Surgeons
therefore will struggle to informatively counsel MoMHA patients
about the risks associated with ARMD revision surgery. Furthermore,
surgeons currently have no robust information regarding the
threshold (when to recommend revision) and type of surgery (what
reconstruction to perform) required in MoMHA patients with ARMD.
This stems from a lack of evidence, which is emphasized by the vari-
ability in the recommendations proposed by different worldwide
regulatory authorities for considering revision [16]. Although some
studies have identiﬁed factors predicting poor outcomes following
ARMD revision, including solid pseudotumors, these have been small
and underpowered [7,15,17,18]. Therefore, surgeons currently have
difﬁculty when managing MoMHA patients with ARMD.
Identifying any prognostic factors of outcome following ARMD
revision would assist surgeons when making decisions regarding
the threshold and type of reconstruction to perform, with this in-
formation also helpful when counseling patients before and after
revision regarding their likely outcomes. Establishing a robust
threshold for recommending ARMD revision surgery is critical, not
only so patients can have surgery at the correct time and obtain the
best possible outcomes but also to prevent individuals being
exposed to unnecessary revisions. A recent registry analysis of 2535
MoMHAs revised for ARMD identiﬁed factors predictive of re-
revision that were surgeon modiﬁable, including the revision
articulation [19]. Although these ﬁndings provide surgeons with
useful information when planning reconstructions for ARMD, reg-
istries do not collect data on important prerevision factors, such as
blood metal ions and cross-sectional imaging, which are crucial for
establishing a threshold for MoMHA revision surgery.
We performed a large retrospective cohort study involving
MoMHA patients undergoing revision surgery for ARMD.We aimed
to determine the outcomes following ARMD revision and identify
predictors of a poor outcome. The latter predictors would be used
to inform the threshold for ARMD revision and the type of
reconstruction.
Materials and Methods
Study Design, Selection Criteria, and Deﬁnitions
We performed a retrospective cohort study involving 2
specialist European arthroplasty centers. The study included all
patients with MoMHAs undergoing revision surgery for ARMD
between January 2001 and March 2016. Cases were identiﬁed from
prospectively maintained institutional databases described previ-
ously [3,17,20,21]. This study was registered with each institution’s
review board, with all patients reviewed according to institutional
follow-up protocols.During the study period, 706MoMHA revisions were performed
for any indication at the 2 centers. There were 346 (49.0%) revisions
performed for conﬁrmed ARMD, which were included in this study.
Both centers were tertiary units involving 16 surgeons. Although all
ARMD revisions were performed at 2 centers, the index MoMHA
surgery could have been performed elsewhere. In addition to pri-
mary MoMHAs requiring revision for ARMD, we also included
primary MoMHAs revised to another MoMHA for non-ARMD in-
dications (eg, hip resurfacing with femoral neck fracture revised to
a stemmed MoMHA), which subsequently required revision for
ARMD.
Preoperative investigations and intraoperative and histopatho-
logical ﬁndings were all used for diagnosing ARMD. Features of
ARMD identiﬁed on preoperative cross-sectional imaging and/or
intraoperatively included metallosis, pseudotumor, synovitis, joint
effusion, tissue damage, and/or necrosis [12,17,22]. A pseudotumor
was deﬁned as a cystic, solid, or mixed mass communicating with
the hip joint [7,12,23]. Histological evidence supportive of ARMD
included lymphocytic inﬁltrates (including aseptic lymphocytic
vasculitis and associated lesions) and/or phagocytic macrophage
responses to metal wear debris, with or without tissue necrosis
[24e26].
Preoperative Investigations
Patients with problematic MoMHAs attended outpatient clinics
for assessment because of one of the following: (1) patients were
symptomatic and were seen either during or in-between scheduled
reviews; (2) patients were discharged but subsequently referred
back by the general practitioner because of new symptoms; (3)
patients were asymptomatic and under surveillance recommended
by regulatory authorities [13,14,27] with abnormalities identiﬁed
during these investigations; and (4) symptomatic or asymptomatic
patients with abnormal investigations were referred from another
center for specialist management.
The routine preoperative investigation of patients with prob-
lematic MoMHAs has been described in detail, including the
methods for blood metal ion sampling and cross-sectional imaging
[3,20,21]. All patients underwent clinical examination and radio-
graphic assessment with standardized anteroposterior pelvic ra-
diographs, with or without a lateral hip radiograph. Most patients
also underwent blood metal ion sampling (cobalt and chromium
concentrations) and cross-sectional imaging (ultrasound and/or
metal artifact reduction sequence magnetic resonance imaging).
However, these investigations were not performed prior to some of
the earliest revisions given that the understanding of ARMD
evolved gradually with time [9,15]. All blood metal ion samples
were analyzed at accredited laboratories, and all cross-sectional
imaging was performed and interpreted by expert musculoskel-
etal radiologists.
Revision Surgery and Follow-Up
The decision to perform revision was made by the patient’s
surgeon based on symptoms and/or investigative ﬁndings. The in-
dications for revision have evolved over time [15,28]. The earliest
revisions were performed in symptomatic patients with large and
sometimes destructive ARMD lesions. However, as outcomes
following these early revisions were poor [9,15], the indications for
ARMD revision surgery were broadened to include mildly symp-
tomatic patients with less severe disease. In general, all diseased
tissue (inﬂamed/necrotic), including pseudotumors, were excised
completely, though this was not possible in all cases because of
proximity to neurovascular structures. The speciﬁc reconstruction
performed for ARMD (which components were removed, the
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and the use of bone graft) was at the discretion of the operating
surgeon. Details of routine postoperative care after revision has
been described [17,29].
After revision, patients were reviewed in clinic at 6 weeks and 1
year postoperatively. Subsequent reviewswere according to clinical
need, usually annually. Consultations included clinical examination,
radiographs (anteroposterior pelviswith orwithout lateral hip), and
completion of the Oxford Hip Score (OHS) questionnaire [30,31].
Patients with pain after revision underwent further investigation as
required, including blood tests (to assess for infection and further
metal ion release), cross-sectional imaging, and joint aspiration.
Data Collection and Outcomes of Interest
Relevant preoperative and intraoperative factors and post-
revision outcomes were collected using standardized data collec-
tion proformas described previously [17,28]. All data were obtained
retrospectively from the clinical notes, the electronic patient re-
cords systems, and the prospectively maintained institutional
databases.
Preoperative variables included age, gender, details of the
MoMHA (includingmanufacturer), unilateral/bilateralMoMHA, local
and systemic symptoms, radiographic ﬁndings, blood cobalt and
chromium concentrations, and cross-sectional imaging abnormal-
ities (including the volume and consistency of any lesions identiﬁed).
Radiographic acetabular component position (inclination and
version) was determined using validated methods with ImageJ
(National Institutes of Health, Bethesda, MD) [32]. Radiographs were
assessed by 2 reviewers blinded to the clinical information, with 50
radiographs assessed by both reviewers. Intraclass correlation co-
efﬁcients between observers were excellent: inclination ¼ 0.979
(95% conﬁdence interval [CI] ¼ 0.955-0.990), version ¼ 0.968 (95%
CI ¼ 0.947-0.988). Acetabular components were considered malpo-
sitioned if one or both parameters were outside the recommended
optimal zone for MoMHAs (inclination 35-55 and anteversion 10-
30) [33]. Each radiograph was systematically analyzed for evidence
of implant failure as described previously, including component
loosening, osteolysis, and heterotopic ossiﬁcation [34].
Intraoperative variables were identiﬁed from the lead surgeon’s
operation records, which were assessed by 1 independent observer
who was not involved with the surgeries and blinded to the pre-
operative investigation ﬁndings. Data extracted included details of
the surgeon, approach, intraoperative ﬁndings (including pseudo-
tumor, effusions, soft-tissue damage, osteolysis, metallosis, syno-
vitis, fracture, infection, necrosis, and component position),
components removed (all, single-component, or modular compo-
nents), and the reconstruction performed.
The study outcomes of interest following ARMD revisionwere as
follows: (1) intraoperative complications; (2) postoperative com-
plications; (3) re-revision surgery, (4) further surgery excluding re-
revision; (5) patient-reported outcome measures (PROMs), and (6)
mortality. Re-revision surgery was deﬁned as removal, exchange, or
addition of any implant. If further surgery was performed else-
where, the respective hospital was contacted to complete data
collection (date, indication, and procedure performed). Both cen-
ters used the OHS (0-48; 48 ¼ best outcome) for postoperative
PROMs. We deﬁned a poor PROM as an OHS under 27 points, as
recommended previously [31,35]. Patients who had not been
reviewed within 12 months were sent a postal PROM and further
surgery questionnaire to complete. All deaths were investigated
using patient notes and information held by the general practi-
tioner to determine whether the death was related to revision
arthroplasty and whether the hip was re-revised or remained in-
situ at the time of death.Statistical Analysis
All statistical analysis was performed using Stata, version 14.2,
(StataCorp., College Station, TX). The signiﬁcance level was P < .05,
with 95% CIs also used. For numerical data, either the median and
interquartile range or the mean and standard deviation or range
were used depending on the data distribution. Implant survival
analysis was performed using the Kaplan-Meier method with re-
revision surgery used as the end point. Patients not undergoing
re-revision were censored at latest follow-up (clinic review, ques-
tionnaire completion, or death).
Logistic regression modeling was used to identify predictors of a
poor outcome. A poor outcome was deﬁned as one or more of the
following: intraoperative complication, postoperative complication,
further surgeryorprocedure (including re-revision),mortalitywithin
90 days of surgery, and poor PROMs. Regression models were based
on a subgroup of patients who all had blood metal ions and cross-
sectional imaging before ARMD revision. Univariable models
explored the association between each predictor and poor outcome.
For continuous predictors, linearity was assessed using fractional
polynomials, with data categorized if the relationship between the
predictor and outcome was nonlinear. Multivariable logistic regres-
sion models were devised based on (1) preoperative factors only
(threshold for surgery) and (2) intraoperative factors only (recon-
struction required). These 2 multivariable models were developed
using stepwise selection methods, with the area under the curve
(AUC) calculated to assess the discriminatory performance of each
model (50% AUC ¼ nondiscriminatory and 100% AUC ¼ perfect
discrimination). The P values for the removal and inclusion of pre-
dictors in the ﬁnal multivariable models were P  .20 and P < .10,
respectively. Regression diagnostics were assessed to ensure all un-
derlying model assumptions were met [36,37]. When developing
predictivemodels, it has been recommended that to ensure sufﬁcient
power, there should be at least 10 outcome events per candidate
variable (ie predictor) assessed, although there is also evidence that
fewer than 10 outcome events per predictor can be satisfactory [38].
Results
There were 346 MoMHAs revised for ARMD that were eligible
for inclusion, with the respective preoperative and intraoperative
factors summarized (Table 1).
Outcomes
Intraoperative complications (all femoral or acetabular frac-
tures) occurred in 1.5% (n ¼ 5). One or more postoperative com-
plications occurred in 17.6% of hips (n ¼ 61), which included
re-revision surgery (n ¼ 33), further surgery excluding re-revision
(n ¼ 28), and complications not requiring surgery (n ¼ 9). Re-
revision surgery was performed at a mean of 1.58 years from
ARMD revision (range ¼ 0.01-6.77 years), with the commonest
indications being dislocation (n ¼ 13; 39.4% of all re-revisions),
ARMD recurrence (n ¼ 5; 15.2%), and aseptic acetabular compo-
nent loosening (n ¼ 5; 15.2%). Death occurred in 2.6% (n ¼ 9) of
patients following ARMD revision (range ¼ 0.07-8.09 years), with
one death occurring within 90 days of surgery. Mean follow-up
time for nonere-revised patients was 4.75 years from revision
(range ¼ 1.0-16.0 years). The cumulative implant survival rate 7
years after ARMD revision was 87.0% (CI ¼ 81.0%-91.2%; 60 hips at
risk) (Figure 1).
The commonest reasons for further surgery excluding re-revision
were closed reductions for dislocation (n ¼ 19; 67.9% of all further
surgery) and washout/debridement for infection/hematoma (n ¼ 4;
14.3%). The commonest complications not requiring surgery were
Table 1
Preoperative and Intraoperative Factors Affecting Outcomes Following ARMD Revision Surgery.
Factor Whole Cohort
(n ¼ 346)
Cohort With Ions &
Imaging (n ¼ 239)
Good Outcome
(n ¼ 147; 61.5%)
Poor Outcome
(n ¼ 92; 38.5%)
Univariate LR Odds
Ratio (95% CI)
P Value
Preoperative factors
Mean age at revision in years (SD) 59.7 (10.8) 59.9 (10.6) 61.0 (9.9) 58.3 (11.5) 0.98 (0.95-1.01) .061
Female gender (%) 231 (66.8) 168 (70.3) 106 (72.1) 62 (67.4) 0.80 (0.45-1.41) .438
Bilateral MoM hips any (%) 118 (34.1) 93 (38.9) 60 (40.8) 33 (35.9) 0.81 (0.47-1.39) .446
Bilateral MoM hips revised for ARMD (%) 46 (13.3) 35 (14.6) 25 (17.0) 10 (10.9) 0.60 (0.27-1.30) .195
Mean time to revision for ARMD (SD) 6.7 (3.3) 7.1 (3.2) 7.4 (3.2) 6.6 (3.3) 0.92 (0.85-1.01) .051
Time to revision under 4 y (%) 72 (20.8) 37 (15.5) 17 (11.6) 20 (21.7) 2.12 (1.05-4.31) .037
Primary and revision center same (%) 249 (72.0) 182 (76.2) 110 (74.8) 72 (78.3) 1.21 (0.65-2.25) .545
Primary revision indication (%)
Primary osteoarthritis 267 (77.2) 180 (75.3) 117 (79.6) 63 (68.5) 1.00 (ref)
Other diagnoses (native hip) 64 (18.5) 47 (19.7) 24 (16.3) 23 (25.0) 1.78 (0.93-3.40) .082
Failed MoM revision surgery 15 (4.3) 12 (5.0) 6 (4.1) 6 (6.5) 1.86 (0.58-6.00) .301
Revision or re-revision of MoM (%)
Revision of primary MoM for ARMD 331 (95.7) 227 (95.0) 141 (95.9) 86 (93.5) 1.00 (ref)
Re-revision (ie previous MoM revision
surgery then developed ARMD)
15 (4.3) 12 (5.0) 6 (4.1) 6 (6.5) 1.64 (0.51-5.25) .405
Primary implant type (%)
Hip resurfacing 245 (70.8) 150 (62.8) 98 (66.7) 52 (56.5) 1.00 (ref)
Total hip arthroplasty 101 (29.2) 89 (37.2) 49 (33.3) 40 (43.5) 1.54 (0.90-2.63) .115
Primary implant design (%)
BHR 154 (44.5) 104 (43.5) 64 (43.5) 40 (43.5) 1.00 (ref)
Other 78 (22.5) 51 (21.3) 34 (23.1) 17 (18.5) 0.80 (0.40-1.62) .534
Conserve 53 (15.3) 29 (12.1) 19 (12.9) 10 (10.9) 0.84 (0.36-1.99) .696
Corail pinnacle 33 (9.5) 29 (12.1) 22 (15.0) 7 (7.6) 0.51 (0.20-1.30) .158
Synergy BHR 28 (8.1) 26 (10.9) 8 (5.4) 18 (19.6) 3.60 (1.43-9.05) .006
Primary implant head size (%)
Less than 46 mm 101 (37.6) 80 (41.7) 52 (46.0) 28 (35.4) 1.00 (ref)
46 mm 82 (30.5) 60 (31.3) 36 (31.9) 24 (30.4) 1.24 (0.62-2.47) .545
Above 46 mm 86 (32.0) 52 (27.1) 25 (22.1) 27 (34.2) 2.01 (0.98-4.09) .055
Symptoms (%)
Local symptoms 323 (93.4) 221 (92.5) 133 (90.5) 88 (95.7) 2.32 (0.74-7.27) .150
Systemic symptoms 2 (0.58) 2 (0.84) 1 (0.68) 1 (1.1) 1.60 (0.10-25.97) .739
Blood metal ions
Median cobalt in mg/l (IQR) 1.92 (0.65-7.50) 1.87 (0.65-8.02) 1.53 (0.29-7.20) 2.62 (0.88-9.40) 1.01 (0.99-1.02) .418
Median chromium in mg/l (IQR) 3.38 (1.51-7.90) 3.51 (1.56-8.30) 3.21 (1.48-8.30) 3.93 (1.75-8.45) 1.00 (0.99-1.02) .828
Radiograph
Mean cup inclination in degrees (SD) 48.7 (10.8) 48.6 (10.8) 48.8 (10.7) 48.4 (11.2) 1.00 (0.97-1.02) .773
Mean cup version in degrees (SD) 18.1 (10.4) 19.4 (10.4) 19.7 (11.1) 18.9 (9.3) 0.99 (0.97-1.02) .594
Cup malposition (%) 183 (52.9) 135 (56.5) 86 (58.5) 49 (53.3) 0.81 (0.48-1.37) .427
Stem/head malposition (%) 5 (1.5) 3 (1.3) 0 (0) 3 (3.3) NA (no events in 1 group) NA
Loose cup (%) 19 (5.5) 9 (3.8) 5 (3.4) 4 (4.4) 1.29 (0.34-4.94) .709
Loose stem (%) 20 (5.8) 11 (4.6) 10 (6.8) 1 (1.1) 0.15 (0.02-1.20) .073
Lysis cup (%) 125 (36.1) 101 (42.3) 65 (44.2) 36 (39.1) 0.81 (0.48-1.38) .439
Lysis stem (%) 58 (16.8) 42 (17.6) 27 (18.4) 15 (16.3) 0.87 (0.43-1.73) .684
Neck thinning (%) 49 (14.2) 34 (14.2) 24 (16.3) 10 (10.9) 0.63 (0.28-1.38) .243
Impingement (%) 1 (0.29) 1 (0.42) 0 (0) 1 (1.1) NA (only 1 event) NA
Heterotopic ossiﬁcation (%) 24 (6.9) 20 (8.4) 7 (4.8) 13 (14.1) 3.29 (1.26-8.60) .015
Any cross-sectional imaging
Any abnormality (% of those with imaging) 265 (84.9) 202 (84.5) 124 (84.4) 78 (84.8) 1.03 (0.50-2.13) .929
Pseudotumors (PTs)
PT numbers (%) 214 (68.6) 163 (68.2) 97 (66.0) 66 (71.7) 1.31 (0.74-2.31) .353
PT consistency (% of all PT)
Cystic 101 (48.1) 71 (44.1) 48 (50.0) 23 (35.4) 1.00 (ref)
Mixed 97 (46.2) 83 (51.6) 46 (47.9) 37 (56.9) 1.68 (0.87-3.24) .123
Solid 12 (5.7) 7 (4.4) 2 (2.1) 5 (7.7) 5.22 (0.94-28.95) .059
PT location (% of all PT)
Anterior ± lateral 88 (42.3) 64 (39.8) 33 (34.4) 31 (47.7) 1.00 (ref)
Posterior ± lateral 61 (29.3) 48 (29.8) 33 (34.4) 15 (23.1) 0.48 (0.22-1.06) .069
Anterior + posterior ± lateral 33 (15.9) 29 (18.0) 20 (20.8) 9 (13.9) 0.48 (0.19-1.21) .120
Other 26 (12.5) 20 (12.4) 10 (10.4) 10 (15.4) 1.06 (0.39-2.91) .903
Median PT volume in cm3 (IQR) 44.7 (14.0-117.2) 44.9 (13.4-130.0) 52.0 (14.4-166.4) 44.7 (13.3-82.8) 1.00 (0.99-1.01) .920
Other image abnormalities
Effusion 60 (19.2) 44 (18.4) 32 (21.8) 12 (13.0) 0.54 (0.26-1.11) .094
Muscle atrophy/damage 24 (7.7) 17 (7.1) 9 (6.1) 8 (8.7) 1.46 (0.54-3.93) .454
Tendon abnormality/damage 16 (5.1) 13 (5.4) 8 (5.4) 5 (5.4) 1.00 (0.32-3.15) .998
Bursal distension/thickening 36 (11.5) 24 (10.0) 17 (11.6) 7 (7.6) 0.63 (0.25-1.58) .325
Intraoperative factors (%)
Median surgeon volume (range) 46 (1-70) 46 (1-70) 46 (3-70) 46 (1-70) 0.99 (0.98-1.01) .460
Center
Center 1 188 (54.3) 166 (69.5) 105 (71.4) 61 (66.3) 1.00 (ref)
Center 2 158 (45.7) 73 (30.5) 42 (28.6) 31 (33.7) 1.27 (0.72-2.23) .403
Posterior approach 253 (73.1) 189 (79.1) 125 (85.0) 64 (69.6) 0.40 (0.21-0.76) .005
(continued on next page)
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Table 1 (continued )
Factor Whole Cohort
(n ¼ 346)
Cohort With Ions &
Imaging (n ¼ 239)
Good Outcome
(n ¼ 147; 61.5%)
Poor Outcome
(n ¼ 92; 38.5%)
Univariate LR Odds
Ratio (95% CI)
P Value
Intraoperative ﬁndings
PT 189 (54.6) 117 (49.0) 75 (51.0) 42 (45.7) 0.81 (0.48-1.36) .419
Effusion 122 (35.3) 93 (38.9) 57 (38.8) 36 (39.1) 1.02 (0.59-1.73) .956
Soft-tissue damage 108 (31.2) 66 (27.6) 35 (23.8) 31 (33.7) 1.63 (0.91-2.89) .098
Soft-tissue necrosis 25 (7.2) 12 (5.0) 4 (2.7) 8 (8.7) 3.40 (0.99-11.65) .051
Cup malposition 82 (23.7) 58 (24.3) 33 (22.5) 25 (27.2) 1.29 (0.71-2.35) .408
Stem/head malposition 16 (4.6) 11 (4.6) 6 (4.1) 5 (5.4) 1.35 (0.40-4.56) .628
Loose cup 14 (4.1) 9 (3.8) 3 (2.0) 6 (6.5) 3.35 (0.82-13.74) .093
Loose stem/head 24 (6.9) 10 (4.2) 8 (5.4) 2 (2.2) 0.39 (0.08-1.86) .235
Lysis cup 184 (53.2) 136 (56.9) 85 (57.8) 51 (55.4) 0.91 (0.54-1.53) .717
Lysis stem 44 (12.7) 30 (12.6) 19 (12.9) 11 (12.0) 0.91 (0.41-2.02) .826
Infection 4 (1.2) 0 (0) 0 (0) 0 (0) NA (no events in 1 group) NA
Neck thinning 12 (3.5) 6 (2.5) 5 (3.4) 1 (1.1) 0.31 (0.04-2.71) .291
Acetabular fracture 4 (1.2) 2 (0.84) 1 (0.68) 1 (1.1) 1.60 (0.10-25.97) .739
Femoral fracture 8 (2.3) 3 (1.3) 3 (2.0) 0 (0) NA (no events in 1 group) NA
Metallosis 171 (49.4) 125 (52.3) 78 (53.1) 47 (51.1) 0.92 (0.55-1.56) .766
Impingement 6 (1.7) 6 (2.5) 4 (2.7) 2 (2.2) 0.79 (0.14-4.43) .793
Synovitis 18 (5.2) 16 (6.7) 8 (5.4) 8 (8.7) 1.65 (0.60-4.57) .332
Revision performed
All components 244 (70.5) 154 (64.4) 98 (66.7) 56 (60.9) 1.00 (ref)
Single component (cup or stem/head) 74 (21.4) 57 (23.9) 28 (19.1) 29 (31.5) 1.81 (0.98-3.35) .058
Modular only (head/liner) 28 (8.1) 28 (11.7) 21 (14.3) 7 (7.6) 0.58 (0.23-1.46) .249
Type of implants
Primary 230 (66.5) 152 (63.6) 93 (63.3) 59 (64.1) 1.04 (0.60-1.79) .892
Revision 116 (33.5) 87 (36.4) 54 (36.7) 33 (35.9) 1.00 (ref)
Revision head size
Less than 36 mm 216 (62.4) 155 (64.9) 91 (61.9) 64 (69.6) 1.00 (ref)
36 mm or above 130 (37.6) 84 (35.1) 56 (38.1) 28 (30.4) 0.71 (0.41-1.24) .228
Cup ﬁxation (% of all those cups revised)
Cementless 295 (98.3) 201 (98.5) 119 (100) 82 (96.5) 1.00 (ref)
Cemented 5 (1.7) 3 (1.5) 0 (0) 3 (3.5) NA (no events in 1 group) NA
Stem ﬁxation (% of all those stems revised)
Cementless 109 (41.6) 82 (50.9) 60 (57.1) 22 (39.3) 1.00 (ref)
Cemented 153 (58.4) 79 (49.1) 45 (42.9) 34 (60.7) 2.06 (1.06-3.99) .032
Revision bearing surface
Ceramic-on-ceramic 78 (22.5) 46 (19.3) 23 (15.7) 23 (25.0) 1.00 (ref)
Metal-on-polyethylene 107 (30.9) 54 (22.6) 37 (25.2) 17 (18.5) 0.46 (0.20-1.04) .061
Ceramic-on-polyethylene 80 (23.1) 70 (29.3) 47 (32.0) 23 (25.0) 0.49 (0.23-1.05) .067
Oxinium-on-polyethylene 78 (22.5) 69 (28.9) 40 (27.2) 29 (31.5) 0.73 (0.34-1.53) .401
Metal-on-metal 3 (0.87) 0 (0) 0 (0) 0 (0) NA NA
Bone graft (acetabular ± femoral) 118 (34.1) 88 (36.8) 59 (40.1) 29 (31.5) 0.69 (0.40-1.19) .180
Statistically signiﬁcant P values (<0.05) highlighted in bold text.
ARMD, adverse reactions to metal debris; BHR, Birmingham Hip Resurfacing; CI, conﬁdence interval; IQR, interquartile range; LR, logistic regression; NA, not available; SD,
standard deviation.
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All adverse events are summarized (Table 2).
In patients not undergoing re-revision, the median OHS was 36
(interquartile range ¼ 25-45). Poor PROMs were observed in 22.8%
(n ¼ 79). Thirty-nine percent (n ¼ 135) of all patients had a poor
outcome following ARMD revision. Of hips with poor outcomes, 117
fulﬁlled 1 criterion for a poor outcome, 17 fulﬁlled 2 criteria, and 1
hip fulﬁlled 3 criteria.
Risk Factors for Poor Outcomes
Predictors of poor outcomes were assessed in 239 patients (69%
of cohort) who all had bloodmetal ions and cross-sectional imaging
prerevision (poor outcome observed in 38.5%; n ¼ 92).
In the univariable analysis, preoperative predictors of a poor
outcome included shorter time (under 4 years) from primary to
revision surgery, revision of a speciﬁc metal-on-metal total hip
arthroplasty design (Synergy BHR), and radiographic evidence of
heterotopic ossiﬁcation (Table 1). Blood metal ions did not predict
poor outcomes. In patients with imaging pseudotumors, the con-
sistency, location, and volume were not associated with poor out-
comes. In the univariable analysis, intraoperative predictors of a
poor outcome were surgical approaches other than posterior and
cemented stem ﬁxation (vs cementless) (Table 1).Predictive Models for Poor Outcomes
Amultivariable model (AUC¼ 68.4%) involving only preoperative
factors identiﬁed one statistically signiﬁcant predictor of a poor
outcome, namely shorter time (under 4 years) from primary to revi-
sion surgery (odds ratio ¼ 2.12; CI ¼ 1.00-4.46; P ¼ .049) (Table 3).
A multivariable model (AUC ¼ 74.0%) involving intraoperative
factors identiﬁed a number of variables which signiﬁcantly inﬂu-
enced outcomes (Table 4). Single-component revisions (acetabular
or femoral; vs all-component revisions: OR ¼ 2.99, CI ¼ 1.50-5.97)
and loose acetabular components at revision (OR ¼ 4.66, CI ¼ 1.04-
20.92) increased the risk of poor outcomes. Intraoperative factors
reducing the risk of poor outcomes included the posterior surgical
approach (OR ¼ 0.22, CI ¼ 0.10-0.49), revision head sizes of 36 mm
and above (vs under 36mm: OR¼ 0.37, CI¼ 0.18-0.77), ceramic-on-
polyethylene revision bearings (OR vs ceramic-on-ceramic ¼ 0.30,
CI ¼ 0.14-0.66), and metal-on-polyethylene revision bearings (OR
vs ceramic-on-ceramic ¼ 0.37, CI ¼ 0.17-0.83).
In patients undergoing ARMD revision where intraoperative
modiﬁable factors were optimized (ie posterior approach, all
components revised, and 36mmor larger ceramic-on-polyethylene
or metal-on-polyethylene bearings used), the risk of a poor
outcome was 10% compared with 40% in patients undergoing
reconstruction with other strategies.
Fig. 1. Kaplan-Meier cumulative implant survival rate following revision surgery performed for adverse reactions to metal debris (ARMD). The shaded area represents the respective
upper and lower limits of the 95% conﬁdence intervals (CIs). Risk table indicates the number of hips at risk at 2-year intervals, with the corresponding number in brackets detailing
the number of hips undergoing re-revision surgery during each 2-year interval.
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Although there is some evidence that outcomes following
ARMD revision have improved since the initial poor short-term
outcomes [9,10], the studies available are small single-center co-
horts with short-term follow-up [8]. We have studied the largest
nonregistry cohort to date, with the 2-center and multisurgeon
design improving the generalizability of our ﬁndings to similar
centers undertaking ARMD revisions. Our large cohort with mid-
term follow-up therefore provides a comprehensive appraisal of
the outcomes following ARMD revision, which can be used toTable 2
Intraoperative and Postoperative Adverse Outcomes Following ARMD Revision Surgery.
Outcome of Interest Number of Hips
Intraoperative complications (5 in total) 1
1
1
1
1
Re-revision surgery (33 in total) 13
5
5
3
3
4
Further surgery not including re-revision (28 in total) 19
4
2
1
1
1
Other complications not needing any surgery (9 in total) 4
2
1
1
1
ARMD, adverse reactions to metal debris.informatively counsel MoMHA patients prerevision about their
likely prognosis.
The risk of intraoperative complications and mortality was
reassuringly low and similar to registry data [19]. Previous
studies have reported implant survival rates of 88%-90% at 3
years to 5 years following ARMD revision [17e19]. Our implant
survival rate at 7 years (87.0%) is therefore similar to these pre-
vious studies and also comparable with the 7 year implant sur-
vival observed in registries after non-MoM revisions for
conventional modes of failure (85%-87% depending on ﬁxation
and articulation) [5]. The commonest re-revision indicationsComplication Details
Greater trochanter fracture (no treatment)
Calcar crack (treated with wires)
Femoral shaft fracture (treated with cables)
Acetabular fracture (no treatment)
Femoral shaft fracture (treated with open reduction and internal ﬁxation)
Dislocation
ARMD recurrence (2 associated with dislocation and/or fracture)
Aseptic acetabular component loosening
Infection
Periprosthetic femoral fracture
Other (1 each of below):
Acetabular component malposition
Reclean of inﬂamed trochanteric bursa and change of modular components
Implant fracture through modular neck
Stem malalignment þ leg length discrepancy
Closed reduction for dislocation under anesthesia
Washout/debridement for wound infection or hematoma
Abductor repair/reattachment
Excision of pseudotumor recurrence (no implants changed)
Psoas release for irritation (arthroscopic)
Stenting of stenotic external iliac artery (claudication)
Superﬁcial wound infection (treated with antibiotics only)
Femoral nerve palsy (1 transient/1 permanent)
Leg length discrepancy (1.5 cm) with neuropathic foot
Deep vein thrombosis
Cellulitis (treated with antibiotics only)
Table 3
Preoperative Predictors of Poor Outcomes Following ARMD Revision Surgery (Multivariable Logistic Regression Model).
Preoperative Factor (AUC ¼ 68.4%) Odds Ratio (95% CI) P Value
Primary surgery factors
Time to ARMD revision under 4 y 2.12 (1.00-4.46) .049
Other diagnoses for native hip eg, dysplasia (vs primary osteoarthritis) 1.81 (0.91-3.62) .093
Failed primary MoM hip revised to another MoM hip (vs primary osteoarthritis) 2.52 (0.68-9.38) .169
Imaging factors
Heterotopic ossiﬁcation on radiograph 2.52 (0.89-7.16) .082
Loose stem on radiograph 0.17 (0.02-1.42) .101
Bursal distension on imaging 0.43 (0.13-1.44) .172
Effusion on imaging 0.56 (0.26-1.25) .158
Muscle atrophy on imaging 3.43 (0.92-12.75) .065
Statistically signiﬁcant P-values (<0.05) highlighted in bold text.
AUC, area under the curve; CI, conﬁdence interval; ARMD, adverse reactions to metal debris.
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acetabular loosening) are consistent with the literature, with the
reasons why ARMD revisions are prone to these modes of failure
described previously [8,19].
Although it is reassuring that the catastrophic short-term
implant failure rates following ARMD revision [9,10] are no longer
observed, it is important to consider other outcomes of interest
including PROMs and postoperative complications. These end
points have not been appraised consistently in previous studies and
are not available in registries [8]. Many patients (39%) experienced
a poor outcome following ARMD revision despite having surgery at
specialist centers by experienced surgeons. The most common
reasons for this were poor PROMs, re-revision surgery, and further
surgery excluding re-revision (namely closed reductions for dislo-
cation). The high risk of a suboptimal outcome following ARMD
revision despite specialist management highlights the importance
of detailed prerevision counseling so patients are fully aware of the
likely outcomes.
Surgeons currently have difﬁculty when managing MoMHA
patients with ARMD with regards to the threshold for revision and
type of reconstruction. This relates to a lack of evidence, with
previous studies being underpowered when assessing predictors of
a poor outcome [7,15,17,18]. Unsurprisingly worldwide regulatory
authorities provide variable recommendations about the revision
threshold [16]. Surgeons therefore largely rely on expert opinion
(level 5 evidence) to manage patients [39e41], which itself has
been shown to be problematic [42]. We believe that our study is the
ﬁrst appropriately powered cohort which attempts to identify
thresholds for revision surgery in MoMHA patients with ARMD
using important preoperative factors.
The only preoperative factor signiﬁcantly predicting a poor
outcome was shorter time (under 4 years) from primary to revi-
sion surgery. The overall clinical performance of the preoperativeTable 4
Intraoperative Predictors of Poor Outcomes Following ARMD Revision Surgery (Multivar
Intraoperative Factor (AUC ¼ 74.0%)
Surgeon volume of revision ARMD cases
Posterior approach for revision (vs other approach)
Intraoperative ﬁndings
Soft-tissue damage at revision
Loose acetabular component at revision
Lysis acetabular component at revision
Pseudotumor at revision
Reconstruction performed
Single-component (acetabular or femoral) revision (vs all component revision)
36 mm or larger revision head (vs less than 36 mm)
Ceramic-on-polyethylene revision bearing (vs ceramic-on-ceramic)
Metal-on-polyethylene revision bearing (vs ceramic-on-ceramic)
Use of bone graft (acetabular ± femoral)
Statistically signiﬁcant P values (<0.05) highlighted in bold text.
AUC, area under the curve; CI, conﬁdence interval.threshold model was therefore poor. Recent data from the Na-
tional Joint Registry for England and Wales also observed that a
shorter time between primary MoMHA and revision for ARMD
was associated with an increased risk of re-revision surgery [19].
We believe the short time between primary and revision pro-
cedures is likely to reﬂect the most aggressive and earliest ARMD
cases where patient, surgical, and implant factors were all mark-
edly suboptimal for undergoing MoMHA. These patients typically
presented before we understood the entity of ARMD with large
destructive lesions requiring early revision, but unfortunately,
they experienced poor results after revision surgery [9,15,43].
Over time, our understanding of ARMD improved, patients un-
derwent regular surveillance (including blood metal ions and
imaging), and the threshold for offering revision surgery was
gradually lowered [9,13e15]. Patients revised for ARMD over more
recent years have therefore had lower blood metal ions and less
severe/destructive imaging, which would account for the majority
of cases we studied. We believe that this may explain why
important preoperative factors (such as ions and imaging) were
not found to be predictors of poor outcomes in the present study
and that the short-time between primary and revision was the
only preoperative predictor which encompassed the early and
most aggressive ARMD cases. However, given the rare use of
MoMHA for a number of years, the widespread awareness of
ARMD, and regular surveillance of MoMHA patients, it is sus-
pected this short time between primary and revision is no longer
relevant for future patients developing ARMD [5,6,13,14].
Blood metal ion concentrations, features on cross-sectional
imaging (including pseudotumor volume/consistency and muscle
damage) and radiographs (including acetabular component posi-
tion and osteolysis) did not predict poor outcomes following ARMD
revision, although this is contrary to some much smaller studies
with shorter follow-up [7,15,17,18]. Our data therefore suggest thatiable Logistic Regression Model).
Odds Ratio (95% CI) P Value
0.99 (0.98-1.01) .104
0.22 (0.10-0.49) <.001
1.62 (0.83-3.18) .158
4.66 (1.04-20.92) .045
1.77 (0.81-3.85) .153
0.52 (0.27-1.01) .054
2.99 (1.50-5.97) .002
0.37 (0.18-0.77) .007
0.30 (0.14-0.66) .003
0.37 (0.17-0.83) .016
0.46 (0.20-1.05) .064
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patients with evidence of ARMD.
Theperformanceof themodel basedon intraoperative factorswas
good, and the model contained numerous modiﬁable factors there-
fore suggesting that surgeons can inﬂuence the outcomes following
ARMD revisions. The only nonmodiﬁable factor was a loose acetab-
ularcomponent at revision,whichhada4.7 fold increased riskofpoor
outcomes. Patients with this poor prognostic feature should be
appropriately counseled postrevision and should undergo more
regular surveillance to monitor osseointegration of the revision
construct given that acetabular component loosening requiring re-
revision has been commonly observed after ARMD revision and ap-
pears to be a complex problem to manage in the presence of ARMD
[8,43]. At the time of ARMD revision, it is also recommended that
surgeons domore thannormal to ensure secure acetabularﬁxation to
facilitate osseointegration, such as by using more screws and/or by
using highly porous implant surfaces. We found that no other intra-
operative ﬁndings, including pseudotumor, soft-tissue necrosis, and
osteolysis, were signiﬁcantly associated with poor outcomes.
Modiﬁable risk factors of poor outcomes included surgical
approach, and the type of revision preformed (including femoral
head size and articulation). Using a posterior approach at revision
was associated with a 78% reduced risk of poor outcomes. Elective
arthroplasty data suggest that the posterior approach is associated
with better PROMs and lower short-term mortality compared with
the anterolateral approach [44,45]. The posterior approach is
considered more muscle sparing than the anterolateral approach.
Problems therefore seen more commonly following the antero-
lateral approach include nerve injury [46], reducedmuscle strength
[47], and limping [48]. These problems invariably inﬂuence patient
mobility and PROMs. It is recognized that a surgeon’s choice of
approach may be limited by the anatomical location of ARMD and/
or the approach used for the primary procedure. However, sur-
geons should attempt to use the posterior approach where possible
for ARMD revisions.
Single-component (acetabular or femoral) revisions were asso-
ciatedwith a 3-fold increased risk of poor outcomes comparedwith
all component revisions. Although some authors have achieved
promising results with this strategy when revising MoMHAs for
ARMD [11], most studies support our ﬁndings, even in non-
MoMHAs revised for ARMD [10,19,29,49]. Although single-
component revisions have advantages, such as reducing the time
and potential morbidity of removing well-ﬁxed components, it is
possible they are being overused, such as in cases where posi-
tioning of the retained component may not be absolutely optimal
[8,19]. We believe there is now good evidence that clinical out-
comes are inferior in single-component MoMHA revisions for
ARMD compared with revising all components, even in stemmed
MoMHAs. Surgeons wishing to use single-component revisions in
selected cases must ensure they appropriately counsel patients
before revision regarding the likely prognosis.
Revision femoral head sizes of 36 mm and above had a 63%
reduced risk of poor outcomes following ARMD revision compared
with smaller sizes. Ceramic-on-polyethylene and metal-on-
polyethylene revision bearings had a 70% and 63% reduced risk of
poor outcomes, respectively, compared with ceramic-on-ceramic
revision bearings. Dislocation is a major problem following ARMD
revision observed here and previously [8]. Hip stability is
compromised in these cases by destruction and/or resection of
affected soft-tissues, and reducing the large diameter MoM bearing
to a smaller non-MoM articulation. Recent registry data also
observed that ceramic-on-ceramic bearings used for ARMD re-
visions were associated with higher re-revision rates, with
ceramic-on-polyethylene performing best [19]. The reasons why
ceramic-on-ceramic bearings have inferior outcomes to hard-on-soft articulations remains unclear; however, we consider there is
nowgood evidence that large-diameter (36mm or above) hard-on-
soft articulations (preferably ceramic-on-polyethylene bearings)
should be used for ARMD revisions.
This study had recognized limitations. Its retrospective nature
introduces potential bias regarding the preoperative (namely cross-
sectional imaging reports) and intraoperative (namely revision
operation records) data collected. We were therefore limited by
assessingonly thedata recorded in these reports,which in somecases
did not categorically conﬁrm or refute the presence of all the abnor-
malities we have presented. Although these issues have been
considered previously [28], it is clear that a similar prospective study
would takemany years to complete; therefore, ourwork provides the
best available evidence in the interim. It is recognized that change in
PROMs may have been more useful for our poor outcome deﬁnition
rather than postrevision PROMs; however, we did not have data on
prerevisionPROMsto calculate this.Owing to thestudies largenature,
we were unable to perform detailed appraisal and grading of the
histopathological specimens [25,26] to determine how these features
correlated with outcomes, which may have provided useful infor-
mation for our models. Similarly, we were unable to review all post-
revision radiographs and perform routine postrevision blood metal
ions, which would have both provided important information on
patients who may require future re-revision surgery. Although we
used comprehensive methods to determine outcomes in all patients,
it is possible some patients may have undergone further surgery
whichwewere unaware of. Finally, our statistical modelswere based
on a subgroup of patients undergoing complete preoperative inves-
tigation (ions and imaging), which may decrease the power of our
models. This was an inevitable limitation given the study was retro-
spective and that the diagnosis and investigation of patients with
ARMD has evolved over time [9,15].Conclusions
This large cohort study demonstrated 39% of patients experience
poor outcomes following MoMHA revision for ARMD. This infor-
mation will allow surgeons to informatively counsel patients pre-
revisionabout theexpectedprognosis.Norobust thresholdexists for
recommending ARMD revision; therefore, surgeons must continue
to make decisions on an individual case basis. Patients undergoing
early revisions (within four-years of primary) and those with loose
acetabular components at revision should be counseled about
potentially experiencing poor outcomes. However our work does
suggest that surgeons can make intraoperative decisions that in-
ﬂuence the outcomes following ARMD revision. We therefore
recommend that the best outcomes following MoMHA revision for
ARMDcanbe achieved if surgeons use the posterior approach, revise
all MoMHA components, and use large-diameter (36 mm or above)
ceramic-on-polyethylene or metal-on-polyethylene articulations.Acknowledgments
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